Graduate studies at Western
|Abstract||Randomized Controlled Trials (RCTs) are currently the gold standard within evidence-based medicine. Usually, they are conducted as sequential trials allowing for monitoring for early signs of effectiveness or harm. However, evidence from early stopped trials is often charged with being biased towards implausibly large effects (e.g., Bassler et al. 2010). To our mind, this skeptical attitude is unfounded and caused by the failure to perform appropriate conditioning in the statistical analysis of the evidence. We contend that a shift from unconditional hypothesis tests in the style of Neyman and Pearson to conditional hypothesis tests (Berger, Brown and Wolpert 1994) gives a superior appreciation of the obtained evidence and significantly improves the practice of sequential medical trials, while staying firmly rooted in frequentist methodology.|
|Keywords||No keywords specified (fix it)|
No categories specified
(categorize this paper)
|Through your library||Only published papers are available at libraries|
Similar books and articles
Roger Stanev (2012). Modelling and Simulating Early Stopping of RCTs: A Case Study of Early Stop Due to Harm. Journal of Experimental and Theoretical Artificial Intelligence 24 (4):513-526.
David J. Torgerson & Carole J. Torgerson (2003). Avoiding Bias in Randomised Controlled Trials in Educational Research. British Journal of Educational Studies 51 (1):36 - 45.
Erik Malmqvist, Niklas Juth, Niels Lynöe & Gert Helgesson (2011). Early Stopping of Clinical Trials: Charting the Ethical Terrain. Kennedy Institute of Ethics Journal 21 (1):51-78.
Jan Sprenger (2009). Evidence and Experimental Design in Sequential Trials. Philosophy of Science 76 (5).
Jeremy Howick (2011). The Philosophy of Evidence-Based Medicine. Wiley-Blackwell, Bmj Books.
Joel Lexchin (2012). Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications. [REVIEW] Science and Engineering Ethics 18 (2):247-261.
David Teira (2011). Bayesian Versus Frequentist Clinical Trials. In Gifford Fred (ed.), Philosophy of Medicine [Handbook of Philosophy of Science, vol. 16],. Elsevier.
David Buchanan & Franklin G. Miller (2005). Principles of Early Stopping of Randomized Trials for Efficacy: A Critique of Equipoise and an Alternative Nonexploitation Ethical Framework. Kennedy Institute of Ethics Journal 15 (2):161-178.
Franklin G. Miller & Howard Brody (2002). What Makes Placebo-Controlled Trials Unethical? American Journal of Bioethics 2 (2):3 – 9.
Jeremy Howick, Against a Priori Judgements of Bad Methodology: Questioning Double-Blinding as a Universal Methodological Virtue of Clinical Trials.
Jacob Stegenga (2011). Is Meta-Analysis the Platinum Standard of Evidence? Studies in History and Philosophy of Science Part C 42 (4):497-507.
Maya J. Goldenberg (2012). Innovating Medical Knowledge: Undestanding Evidence-Based Medicine as a Socio-Medical Phenomenon. In Nikolaos Sitaras (ed.), Evidence-Based Medicine: Closer to Patients or Scientists? InTech Open Science.
John PA Ioannidis (2008). Effectiveness of Antidepressants: An Evidence Myth Constructed From a Thousand Randomized Trials? [REVIEW] Philosophy, Ethics, and Humanities in Medicine 3 (1):14.
Robyn Bluhm (2009). Some Observations on “Observational” Research. Perspectives in Biology and Medicine 52 (2):252-263.
Added to index2012-11-09
Total downloads3 ( #213,863 of 739,447 )
Recent downloads (6 months)2 ( #37,288 of 739,447 )
How can I increase my downloads?